We found 490 records for "Regulatory / compliance"

Articles

10 social media events that changed healthcare in 2014

18th December 2014

 10 social media events that changed healthcare in 2014Articles

This month, Daniel Ghinn reviews some of the key online happenings that have had an impact on healthcare over the year.The year 2014 has been incredible for social media in...

Read more

Early Access: the ground rules for communicating with physicians and patients

16th December 2014

 Early Access: the ground rules for communicating with physicians and patientsArticles

How should medical departments, advocacy liaison leaders and communication teams in pharma companies deal with demand for early access to investigational medicines?The last few years have seen a rapid increase...

Read more

Funding rare disease treatments in the UK – navigating the labyrinth

5th December 2014

 Funding rare disease treatments in the UK – navigating the labyrinth Articles

With the appraisal process for highly specialised treatments in the UK described by one NHS insider as 'impenetrable', and The MPS Society's (The Society for Mucopolysaccharide Diseases) recent launch of...

Read more

'Quantified Self' data versus privacy concerns

3rd December 2014

 'Quantified Self' data versus privacy concernsArticles

As data tracking and collection increase, a balance has to be struck between the benefits to health from increased knowledge and the intrusion on individual privacy that results.The 'Quantified Self'...

Read more

News

NICE recommends Pfizer's kidney cancer treatment Inlyta

16th December 2014

 NICE recommends Pfizer's kidney cancer treatment InlytaNews

Pfizer is set to gain a NICE recommendation for its renal cell carcinoma treatment Inlyta, two years after its launch.The drug is to be used as second line therapy after...

Read more

GSK seeks EU extension for Volibris in pulmonary arterial hypertension

12th December 2014

 GSK seeks EU extension for Volibris in pulmonary arterial hypertensionNews

GlaxoSmithKline (GSK) has filed a regulatory submission to the European Medicines Agency (EMA) to extend the Marketing Authorisation for Volibris (ambrisentan) for initial combination therapy for patients with pulmonary arterial...

Read more

Shire to develop mRNA technology with $15m cystic fibrosis collaboration

11th December 2014

 Shire to develop mRNA technology with $15m cystic fibrosis collaborationNews

Shire is collaborating with Cystic Fibrosis Foundation Therapeutics (CFFT), the non-profit R&D arm of the Cystic Fibrosis Foundation, to support its Messenger RNA (mRNA) technology platform for CF.CFFT has committed...

Read more

AstraZeneca novel constipation drug approved in EU

9th December 2014

 AstraZeneca novel constipation drug approved in EUNews

AstraZeneca's (AZ) Moventig (naloxegol) has been granted Marketing Authorisation by the European Commission (EC) for the treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response...

Read more

White Papers

"The future ain’t what it used to be"

25th November 2014

 "The future ain’t what it used to be"White Papers

Preparation is key to creating and maintaining a strong drugs pipeline. However, the statistics demonstrate that successful product commercialisation strategies are not always implemented. Products are developed for which there...

Read more

Healthcare Innovation: the big ideas shaping the future of pharma

17th November 2014

 Healthcare Innovation: the big ideas shaping the future of pharmaWhite Papers

The transformation taking place in healthcare is challenging for everyone and adaptability is key for the pharma industry's continued success.Long production cycles, concentration on specialist drugs with high price tags,...

Read more

How pharma Tweetchats can drive healthcare innovation

29th April 2014

 How pharma Tweetchats can drive healthcare innovationWhite Papers

During the course of 2013 Boehringer Ingelheim explored the use of multi-way communication on Twitter, via Tweetchats, as a means to better understand disease area issues and directly connect with...

Read more

Who are the pharma social media butterflies?

19th March 2014

 Who are the pharma social media butterflies?White Papers

Social media has got everyone talking and it seems like everyone in pharma is talking about social media, so Ogilvy Healthworld figured it was time to analyse who were the...

Read more

Audio & Video

On demand webinar: The Price is Right? - Delivering UK access for niche patient populations

  With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the ramifications for high priced/innovative treatments delivering beneficial outcomes...

Read more

Rare Disease Day tweetchat

  To view a full transcript of the discussion from this #hcsmeu tweetchat held on 28th February 2014 please click here. During the hour-long tweetchat, we covered the following questions:   1) What are...

Read more

Events

Pharmaceutical Microbiology

21st January 2015 - 22nd January 2015

Pharmaceutical Microbiology

Set to take place on 21st and 22nd January 2015, the 4th annual event in the sell-out Pharmaceutical Microbiology series will bring together all levels of industry professionals, providing essential...

Read more

The European Medical Devices Regulation

27th January 2015 - 28th January 2015

The European Medical Devices Regulation

European Medical Device Regulations in September 2012, industry has been attempting to gain a firm idea of what needs to be done to ensure preparation and compliance. Informa Life Sciences’...

Read more

5th Annual Pharma R&D Asia Congress

27th January 2015 - 28th January 2015

5th Annual Pharma R&D Asia Congress

The 5th Annual Pharma R&D World Asia congress will discuss novel scientific innovations in Discovery and Development in Asia. Topics will cover: global collaboration, changes in the model of CRO...

Read more

7th annual Pre-Filled Syringes

28th January 2015 - 29th January 2015

7th annual Pre-Filled Syringes

Join Pre-Filled Syringes- 2015 and be part of a major networking opportunity providing intimate interaction with your peers, where you will hear case studies, presentations and round table discussions on...

Read more

Press Releases

OPEN Health introduces its market access division OPEN Access Consulting

8th December 2014

OPEN Health introduces its market access division OPEN Access Consulting

Marlow, 4 December 2014: OPEN Health announced the launch of its dedicated market access division, OPEN Access Consulting. OPEN Access Consulting brings together existing market access expertise from Succinct Medical Communications...

Read more

3 TIPS FOR PATIENT ENGAGEMENT; DEFINE, ACT THEN ACCELERATE

23rd September 2014

3 TIPS FOR PATIENT ENGAGEMENT; DEFINE, ACT THEN ACCELERATE

Forbes blogger Leonard Kish described “patient engagement as the blockbuster drug of the century” namely for its potential impact on improving patient outcomes. Two years on from his article, I asked;...

Read more

PMCPA selects The EarthWorks as communications partner and app developer for new code

28th July 2014

PMCPA selects The EarthWorks as communications partner and app developer for new code

The Prescription Medicines Code of Practice Authority (PMCPA) announced today that it will be working in partnership with The EarthWorks to create a communications programme, including an app to help...

Read more

New WMF article on global healthcare gaps published

29th May 2014

New WMF article on global healthcare gaps published

WMF recently published an article in Pharmaceutical Physician, which looks at the shocking gaps in healthcare that exist across the world and summarises how the organisation is helping to improve...

Read more